MIM
LEGN icon

Macroview Investment Management’s Legend Biotech LEGN Stock Holding History

Macroview Investment Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-36
Closed -$1.75K – 331
2024
Q3 		$1.75K Hold
36
– – ﹤0.01% 493
2024
Q2 		$1.59K Hold
36
– – ﹤0.01% 501
2024
Q1 		$2.02K Hold
36
– – ﹤0.01% 536
2023
Q4 		$2.17K Sell
36
-99
-73% -$6.27K ﹤0.01% 519
2023
Q3 		$9.07K Sell
135
-9
-6% -$625 0.01% 292
2023
Q2 		$9.94K Buy
+144
New +$9.41K 0.02% 275

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Macroview Investment Management's LEGN Position: Q4 2024 in Review

Macroview Investment Management sold out of Legend Biotech (LEGN) in Q4 2024, closing a stake of 36 shares — an estimated $1.75K sold.

Macroview Investment Management first reported a position in LEGN in Q2 2023 and held it in 6 quarters. The position peaked at $9.94K in Q2 2023. 211 funds tracked by Wall St. Rank hold LEGN as of Q4 2024.

  • Macroview Investment Management reported no remaining Legend Biotech position as of Q4 2024 after selling out during the quarter.
  • Macroview Investment Management sold 36 Legend Biotech shares in Q4 2024, an estimated $1.75K.
  • Macroview Investment Management first reported a position in Legend Biotech in Q2 2023 and held it in 6 quarters.
  • Macroview Investment Management's Legend Biotech position peaked at $9.94K in Q2 2023.
  • 211 funds tracked by Wall St. Rank held Legend Biotech as of Q4 2024.

Based on Macroview Investment Management's 13F filing for Q4 2024, filed 31 Jan 2025.